Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys

Dopaminergic medications ameliorate many of the motor impairments of Parkinson’s disease (PD). However, parkinsonism is often only partially reversed by these drugs, and they can have significant side effects. Therefore, a need remains for novel treatments of parkinsonism. Studies in rodents and pre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ACS Chem Neurosci
Autors principals: Galvan, Adriana, Devergnas, Annaelle, Pittard, Damien, Masilamoni, Gunasingh, Vuong, Jocelyn, Daniels, J. Scott, Lindsley, Craig W., Morrison, Ryan D., Wichmann, Thomas
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510653/
https://ncbi.nlm.nih.gov/pubmed/27596273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.6b00186
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars